CSL Limited ( CMXHF) - Key Metrics
CMXHF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $15.24 | -$6.13 | $4.35 | $3.68 |
| 2026Q2 | $17.45 | $0.84 | $2.74 | $2.12 |
| 2025Q4 | $14.99 | $2.13 | $5.04 | $4.45 |
| 2025Q2 | $16.97 | $4.15 | $2.60 | $1.82 |
| 2024Q4 | $13.94 | $1.53 | $3.50 | $2.73 |
CMXHF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | -19.10% | -3.27 |
| 2026Q2 | 196.01% | 34.38 |
| 2025Q4 | 66.26% | 19.14 |
| 2025Q2 | 40.01% | 10.07 |
| 2024Q4 | 76.79% | 31.37 |
CMXHF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 4.59% | 1.46% |
| 2026Q2 | 1.83% | 1.43% |
| 2025Q4 | 2.73% | 0.87% |
| 2025Q2 | 1.09% | 0.99% |
| 2024Q4 | 1.42% | 0.61% |
CMXHF
Price: $126.18
Dividend Yield: 2.30%
Forward Dividend Yield: 5.14%
Payout Ratio: 43.59%
Dividend Per Share: 6.48 USD
Earnings Per Share: 6.17 USD
P/E Ratio: 17.20
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Market Capitalization: 60.7 billion
Average Dividend Frequency: 3
Years Paying Dividends: 33
DGR3: 30.00%
DGR5: 26.52%
DGR10: 15.30%
DGR20: 18.06%